Tag Archives: Start

Despite rough start, Biogen’s Aduhelm should find footing, analysts say. But don’t expect much in 2021

As Biogen’s new Alzheimer’s drug Aduhelm makes headlines nearly every day—many covering the drug’s slower-than-expected uptake—one team of biopharma analysts is lowering its 2021 expectations for the med. Nonetheless, despite the drug sputtering out the gate, the team still sees a multibillion-dollar sales opportunity for the company in Alzheimer’s disease. Writing to investors Wednesday, analysts with RBC Capital Markets… Read More »

Confusion remains about ONC information blocking rules, even after start date

A poll taken this past month found that many healthcare industry stakeholders were still confused about federal information blocking rules – even though they were finalized more than a year ago and their new April 5 start date has been long publicized.   Now that the info blocking rules drafted by the Office of the… Read More »

African studies explore reasons to start, stick with or stop PrEP

This year’s HIV Research for Prevention (HIVR4P) virtual conference featured a large number of sessions examining PrEP usage and discontinuation rates among a variety of users, especially in Africa. Many of the presentations looked at factors that worked as incentives to keep taking PrEP. There is interest in this because, despite higher initiation rates in a… Read More »